Vergoeding 2018-2022 voor ATC-subgroep N06AB : Selectieve serotonine-heropnameremmers
- Raming voor de totale Zvw-populatie
| 2018 | 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|
| N06AB03 Fluoxetine (Prozac ®) | 818.890 | 1.001.600 | 1.559.900 | 1.233.800 | 1.357.800 |
| N06AB04 Citalopram (Cipramil ®) | 3.534.600 | 3.873.300 | 3.883.700 | 3.401.300 | 3.648.000 |
| N06AB05 Paroxetine (Seroxat ®) | 3.712.400 | 3.894.700 | 4.227.800 | 4.325.800 | 4.470.500 |
| N06AB06 Sertraline (Zoloft ®) | 1.996.300 | 2.033.600 | 2.085.700 | 2.111.400 | 2.580.300 |
| N06AB08 Fluvoxamine (Fevarin ®) | 752.020 | 755.020 | 761.890 | 819.430 | 771.310 |
| N06AB10 Escitalopram (Lexapro ®) | 1.461.000 | 1.709.700 | 2.038.700 | 2.084.100 | 2.232.200 |
| Totaal | 12.275.210 | 13.267.920 | 14.557.690 | 13.975.830 | 15.060.110 |